Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support ...

Enter Project Jedi, which launched in 1984. The project was a five-month experiment named after “Star Wars’” Jedi knights.

None ...

Andrew Oddy looks back on his career as Keeper of Conservation at the British Museum and the exposure test that bears his name ...

Q4 2025 Earnings Call February 11, 2026 2:30 AM ESTCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne - ...

HAICANG DISTRICT, XIAMEN, FUJIAN, CHINA, January 21, 2026 /EINPresswire.com/ -- In a fast-changing global market for ...

Logitech's X2 Superstrike mouse was developed for pro players - but do its haptic inductive clicks work well for casual gamers too? IGN investigates Logitech's latest ultra-light.

Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsAndrew Somberg - VP of Investor Relations ...

Foreign investors should assess Vietnam’s year-end closing rules, statutory audits, tax risks, and profit repatriation limits ...

Louisville is leading the charge in a handful of robotic-assisted surgeries, attracting patients from across the globe ...

China's luxury market shifts from Western dominance to local innovation. How emerging Chinese brands are redefining competition with technology and a new approach to value.

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.